Pfizer sells Capsugel to KKR; Ugene's al peptide drug delivery tech validated;

> Pfizer is selling its Capsugel drug-delivery business to KKR for $2.375 billion in cash, Pfizer announced Monday. Capsugel offers a variety of products, including liquid formulations as part of its Licaps Drug Delivery System. News

> Unigene Laboratories claims a Phase III trial has validated its oral peptide drug delivery technology. Item

> Amgen is looking for an executive director of drug delivery engineering in Thousand Oaks, CA. Job listing

> UK-based biotech companies Critical Pharmaceuticals and PolyTherics are collaborating on an injectable, sustained-release drug-delivery system. Release